Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the NMPA
BOSHUTAI® (Acarbose Tablets) successfully selected for Henan thirteen provinces alliance procurement
Uni-Bio Science Group and Global Cosmetics reach a strategic cooperation on the development of new skincare raw materials
Uni-Bio Science Group and NAMI reach a strategic cooperation to Co-Develop an innovative formulation of EGF
Uni-Bio Science Group and Alephoson Biopharmaceuticals reach a strategic cooperation to Co-Develop Next-generation Best-in-class Compounds
Uni-Bio Science Group and DotBio reach a strategic cooperation to Co-Develop multi-specific DotBodies for people with retinal diseases
The NMPA Granted Marketing Approval for BOSHUTAI® (Acarbose Tablets) in China
Uni-Bio Science Group receives BE Certification for PINUP® (Voriconazole Tablets) by the NMPA
Uni-Bio Science Group receives IND Approval for Uni-PTH Liquid Injection by the NMPA
Uni-Bio Science Group and Medlink builds strategic partnership,expansion of value chain towards pharmaceutical E-commerce
CollaborationbetweenUni-BioScienceGroupandSwisscompanyYpsomedto jointlydevelop2ndgenerationdiabetesandosteoporosisproducts
Strategic Partnership formed between Uni-Bio, Sinopharm Weiqida and Suzhou Yingli for Acarbose development
Uni-Bio Science Group successfully acquire capital injection by fund with state-owned background
Uni-PTH accepted for CFDA review
Uni-Bio Science and Beijing Baiao Pharmaceutical entered into strategic cooperation agreement on the development of oral antidiabetic drugs, Acarbose tablets
HeungKong Great Health Fund I inject HKD$120 million into Uni-Bio Science, and becomes its strategic shareholder
Uni-Bio Science in Multiple Drug Co-development Deal with Beijing Sun-Novo
Uni-Bio Science forges Strategic Alliance with China Resource Zizhu for GeneSoft®
Uni-Bio Science receives newest cCMP certification for its manufacturing line in Beijing
Uni-Bio Science announces positive phase lll results forUni-E4 in Type 2 diabetes
Uni-Bio Science forms strategic partnership with Korean pharmaceutical company Samil Pharmaceuticals
Uni-Bio Science receives newest cCMP certification for its manufacturing line in Shenzhen
Received national grants for Uni-E4 as key innovative project
Shenzhen Watsin becomes a wholly owned subsidiary of Uni-Bio Science Group
Received provincial grant from Guangzhou province in recognition of Uni-PTH and Uni-E4 as key innovative projects.
Beijing Genetech becomes wholly owned subsidiary of Uni-Bio Science Group.
Uni-Bio Science Group lists on Hong Kong Stock Exchange
京公网安备 11011402013046号京ICP备17029593号-2
